Assignee
KING CLIFFORD RILEY
US·20 granted patents·105 citations·filing 2009–2012
Top patents by PatentIndex Score
20 records- 0198US8980880B1Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorderKING CLIFFORD RILEY·Filed 2012·Granted Mar 17, 2015·25 cites·56 claims
- 0296US8338444B1Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping propertiesKING CLIFFORD RILEY·Filed 2011·Granted Dec 25, 2012·16 cites·43 claims
- 0395US8476291B1Opioid salts and formulations exhibiting anti-abuse and anti-dumping propertiesKING CLIFFORD RILEY·Filed 2011·Granted Jul 2, 2013·13 cites·18 claims
- 0495US8329720B1Opioid salts and formulations exhibiting abuse deterrent and anti-dose dumping propertiesKING CLIFFORD RILEY·Filed 2011·Granted Dec 11, 2012·16 cites·33 claims
- 0594US9226925B1Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorderKING CLIFFORD RILEY·Filed 2012·Granted Jan 5, 2016·9 cites·31 claims
- 0692US9421266B2Safety of pseudoephedrine drug productsKING CLIFFORD RILEY·Filed 2012·Granted Aug 23, 2016·11 cites·48 claims
- 0789US8916587B1Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorderKING CLIFFORD RILEY·Filed 2012·Granted Dec 23, 2014·3 cites·4 claims
- 0889US8586575B1Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorderKING CLIFFORD RILEY·Filed 2012·Granted Nov 19, 2013·3 cites·9 claims
- 0985US8569330B1Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping propertiesKING CLIFFORD RILEY·Filed 2011·Granted Oct 29, 2013·2 cites·34 claims
- 1085US8211905B1Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping propertiesKING CLIFFORD RILEY·Filed 2009·Granted Jul 3, 2012·2 cites·36 claims
- 1184US8569329B1Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping propertiesKING CLIFFORD RILEY·Filed 2011·Granted Oct 29, 2013·2 cites·64 claims
- 1283US8653106B2Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorderKING CLIFFORD RILEY·Filed 2010·Granted Feb 18, 2014·1 cites·9 claims
- 1380US8921386B1Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping propertiesKING CLIFFORD RILEY·Filed 2012·Granted Dec 30, 2014·2 cites·68 claims
- 1469US8957067B1Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorderKING CLIFFORD RILEY·Filed 2012·Granted Feb 17, 2015·0 cites·1 claims
- 1569US8940729B1Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorderKING CLIFFORD RILEY·Filed 2012·Granted Jan 27, 2015·0 cites·27 claims
- 1669US8912217B1Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorderKING CLIFFORD RILEY·Filed 2012·Granted Dec 16, 2014·0 cites·18 claims
- 1769US8716337B1Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorderKING CLIFFORD RILEY·Filed 2012·Granted May 6, 2014·0 cites·10 claims
- 1869US8716278B1Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorderKING CLIFFORD RILEY·Filed 2012·Granted May 6, 2014·0 cites·4 claims
- 1969US8653065B1Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorderKING CLIFFORD RILEY·Filed 2012·Granted Feb 18, 2014·0 cites·3 claims
- 2067US8748416B1Opioid salts and formulations exhibiting anti-abuse and anti-dumping propertiesKING CLIFFORD RILEY·Filed 2011·Granted Jun 10, 2014·0 cites·51 claims
Join the waitlist — get patent alerts
Get an alert when KING CLIFFORD RILEY files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →